(Editor’s Note: This is third in a series of articles on the corn test plots planted by Andrew McCrea in early May at his northwest Missouri farm. In his own words, McCrea gives an overview of his ...
- PIVOT-006 Phase 3 topline data evaluating cretostimogene monotherapy for intermediate-risk NMIBC now expected in 1H 2026, nearly one year ahead of schedule - First randomized registrational trial to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results